M&A Features

FMC to purchase NxStage

Germany’s Fresenius Medical Care (FMC) is expanding in the US by acquiring medical devices maker NxStage in a cash deal worth about USD 2,000 million. The purchaser is offering to pay USD 30 per share, representing a 30 per cent premium over the target’s close of USD 23 on 4th August 2017, the last trading day prior to the deal being announced. Adams Street Partners, a private equity firm invested in NxStage, will make a full exit if the transaction goes through.